CVE-2012-0313

Name: CVE-2012-0313
Creator: NVD / NIST
Published: 2012-01-24T04:03:36.567+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

UnknownEPSS 1.14%

Last modified Jun 16, 2026

CVE-2012-0313 is a vulnerability of currently unknown severity. Cross-site scripting (XSS) vulnerability in glucose 2 before stage 6.2 allows remote attackers to inject arbitrary web script or HTML via an RSS feed.. EPSS estimates a 1.14% chance of exploitation in the next 30 days.

Description

Cross-site scripting (XSS) vulnerability in glucose 2 before stage 6.2 allows remote attackers to inject arbitrary web script or HTML via an RSS feed.

Metrics

EPSS Probability

1.14%

62.4th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

CWE-79

Affected Software

Vendor	Product	Versions
Glucose	Glucose 2	<= stage6.1
Glucose	Glucose 2	beta_stage_5
Glucose	Glucose 2	beta_stage_5.1
Glucose	Glucose 2	stage6

References

Timeline

Published: Jan 24, 2012
Last Modified: Jun 16, 2026
Status: Modified

Frequently Asked Questions

What is CVE-2012-0313?

Cross-site scripting (XSS) vulnerability in glucose 2 before stage 6.2 allows remote attackers to inject arbitrary web script or HTML via an RSS feed.

How severe is CVE-2012-0313?

Severity scoring for CVE-2012-0313 is pending analysis. The EPSS model estimates a 1.14% probability of exploitation in the next 30 days.

How do I fix CVE-2012-0313?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2012-0313?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST